Anatomic Pathology Market: Anticipating Strong 8.2% CAGR Growth by 2030, According to FMI

Through the analysis of tissue samples to recognise and comprehend distinct pathological situations, the field of anatomic pathology plays a significant role in the diagnosis and treatment of disease. The Anatomic Pathology Market has shown significant growth and development due to technology improvements and rising demand for precise diagnostic solutions. This blog examines the anatomic pathology market's current position, key drivers, difficulties, and attractive growth prospects.

The prevalence of chronic diseases like cancer, cardiovascular problems, and infectious diseases is on the rise, which has been a major driver of the anatomic pathology industry. Advanced techniques including immunohistochemistry, digital pathology, and molecular pathology have been used because accurate and effective diagnostic tools are required. This has allowed for more accurate disease characterization and individualised therapy options.

𝐆𝐞𝐭 𝐘𝐨𝐮𝐫 𝐇𝐚𝐧𝐝𝐬 𝐎𝐧 𝐎𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐒𝐭𝐚𝐲 𝐔𝐩-𝐓𝐨-𝐃𝐚𝐭𝐞 𝐎𝐧 𝐓𝐡𝐞 𝐋𝐚𝐭𝐞𝐬𝐭 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭𝐬 𝐈𝐧 𝐓𝐡𝐞 𝐀𝐧𝐚𝐭𝐨𝐦𝐢𝐜 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭! https://www.futuremarketinsights.com/reports/sample/rep-gb-12370

The expected size of the global anatomic pathology market in 2022 was US$ 32.5 million, and by the end of 2030, it is projected to have grown to US$ 61.1 million, with a strong CAGR of 8.2%. The increased usage of anatomic pathology in illness diagnosis and the development of new drugs is what is fueling the growth of the worldwide anatomic pathology market. The global anatomic pathology market is expected to produce sales of US$ 61.1 million by 2030, according to a recent industry report by Future Market Insights (FMI), an ESOMAR-certified market research firm.

The anatomic pathology market has many prospects for expansion, but it also has some difficulties. These include the high cost of cutting-edge diagnostic tools, the scarcity of experts with the necessary skills, and onerous regulatory restrictions. However, remote diagnostics have become possible thanks to the growing use of digital pathology and telepathology systems, making it possible to receive professional opinions and lighten the workload for pathologists.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬:

• The instruments are subject to technological advancements, which would minimize errors. This factor is expected to drive the anatomic pathology market between 2022 and 2030

• Consumables are expected to hold the largest market share due to low cost, high availability, and good purchase rate of probes and reagents.

• Academic research is bound to pick up pace in the forecast period owing to growing implementation of anatomic pathology in biomarker profiling and tumor examination.

• Preference to personalized therapies is prompting putative biomarkers being discovered. This factor is expected to be one of the key growth drivers.

"The anatomic pathology market is witnessing a continuous upswing on the part of biomarkers. This factor is expected to propel the development of anatomic pathology market" - says the FMI analyst.

𝐊𝐞𝐲 𝐏𝐚𝐫𝐭𝐢𝐜𝐢𝐩𝐚𝐧𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

The key market players are focusing on technological upgradations and expansion strategies to keep themselves fiercely competitive.
For instance:

• In Jul 2020, Bio SB tabled its Fast Mohs PolyDetector Plus Detection System, which comes across as a super sensitive nonbiotin monovalent Fab micropolymer immunohistochemistry system to detect IVD antibodies for squamous cell carcinoma, basal cell carcinoma, and melanoma.

• In Jan 2019, Quest Diagnostics announced completion of acquisition of the US laboratory services business that belonged to Oxford Immunotec (the T-Spot and Accutix tick-borne disease testing services, since then, are part of Quest's infectious disease testing services.

• In 2018, Leica Microsystems entered into a collaboration with Thermo Fisher to develop an integrated cryotomography workflow with regards to research.

𝐄𝐦𝐛𝐫𝐚𝐜𝐞 𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐎𝐟 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐖𝐢𝐭𝐡 𝐎𝐮𝐫 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐝 𝐌𝐞𝐭𝐡𝐨𝐝𝐨𝐥𝐨𝐠𝐲! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-12370

𝐊𝐞𝐲 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐩𝐫𝐨𝐟𝐢𝐥𝐞𝐝:

• Laboratory Corporation of America Holdings
• Sakura Finetek USA, Inc.
• F.Hoffmann-La Roche AG
• Cardinal Health, Inc.
• BioGenex
• NeoGenomics
• Agilent Technologies

The US continues to be one of the leading markets for anatomic pathology market globally. Strong presence of some of the leading players, combined with relatively easier funding for R&D will drive the US anatomic pathology market during the assessment period.

The Europe anatomic pathology market is also likely to grow at a brisk pace during the assessment period. The growth will remain concentrated in Western Europe, as has been the case traditionally.

Asia Pacific represents a high growth market for anatomic pathology stakeholders. Many countries in the region are renewing their focus on healthcare, as the current Covid-19 crisis has reinforced the necessity of a robust healthcare system.

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐨𝐟 𝐀𝐧𝐚𝐭𝐨𝐦𝐢𝐜 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐮𝐫𝐯𝐞𝐲:

𝐀𝐧𝐚𝐭𝐨𝐦𝐢𝐜 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭 & 𝐒𝐞𝐫𝐯𝐢𝐜𝐞:

• Anatomic Pathology Instruments
• Anatomic Pathology Consumables
• Anatomic Pathology Services

𝐀𝐧𝐚𝐭𝐨𝐦𝐢𝐜 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧:

• Disease Diagnosis
• Drug Discovery and Development
• Others

𝐀𝐧𝐚𝐭𝐨𝐦𝐢𝐜 𝐏𝐚𝐭𝐡𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐄𝐧𝐝 𝐔𝐬𝐞𝐫:

• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Others

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐨𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

Endodontics and Orthodontics Market: https://www.futuremarketinsights.com/reports/endodontics-and-orthodontics-market

Hypoparathyroidism Treatment Market: https://www.futuremarketinsights.com/reports/hypoparathyroidism-treatment-market

Surgical Generators Market: https://www.futuremarketinsights.com/reports/surgical-generators-market

𝐀𝐛𝐨𝐮𝐭 𝐅𝐮𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 (𝐅𝐌𝐈)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:

Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
𝐅𝐨𝐫 𝐒𝐚𝐥𝐞𝐬 𝐄𝐧𝐪𝐮𝐢𝐫𝐢𝐞𝐬: sales@futuremarketinsights.com
𝐖𝐞𝐛𝐬𝐢𝐭𝐞: https://www.futuremarketinsights.com
𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.futuremarketinsights.com/reports/anatomic-pathology-market

This release was published on openPR.